TFF Pharmaceuticals
Call now
Call now
Website
Call
TFF Pharmaceuticals
Our patented Thin Film Freezing (TFF) platform makes it possible to turn more molecules into inhalable therapies. This novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. Learn about the problems with inhalables and the benefits of our Thin Film Freezing platform.

We are excited to have two products in development for lung diseases. Our enabling TFF platform technology has almost limitless potential in a multitude of therapeutic arenas. We are focused on developing innovative drug products based on our patented Thin Film Freezing (TFF) technology platform.
Services
Early in vitro testing conrms our TFF platform can signicantly improve the solubility of poorly water soluble drugs, a class of drugs that makes up more than one-third of the major pharmaceuticals worldwide. In the case of some new drugs that cannot be developed due to poor water solubility, our TFF platform has the potential to improve the pharmacokinetic profile of the drug.
The 505(b)(2) pathway is intended for molecules that have been previously approved by the FDA as safe and effective. This can include reformulation of the known molecule in a new strength or dosage form. 505(b)(2) products have the advantage of potentially signicantly lower development costs and shorter development timelines versus traditional new molecular entities.
Our history tells us that great achievements are attained through strategic collaborative partnerships. We are dedicated to our patients and our business, and we are open to explore more creative ways of partnering that can transform a partnership into a long-term strategic & collaborative alliance.
Reviews
Review TFF Pharmaceuticals

Be the first to review TFF Pharmaceuticals.

Write a Review